Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing

This study has been completed.
Information provided by:
Tibotec Pharmaceuticals, Ireland Identifier:
First received: July 10, 2009
Last updated: May 18, 2011
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):